We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
Read MoreHide Full Article
Key Takeaways
Encompass Health plans a 36-bed rehabilitation hospital in Bridgeport, expanding regional capacity.
The facility replaces a closed 19-bed unit and supports patients recovering from complex conditions.
EHC continues its multi-year growth strategy with new hospitals and bed additions amid rising demand.
Encompass Health Corporation (EHC - Free Report) is continuing to expand its rehabilitation network with plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, WV. The freestanding facility will provide specialized care for patients recovering from strokes, spinal cord injuries, brain injuries, amputations, neurological disorders and complex orthopedic conditions.
The project represents an expansion and relocation of the former 19-bed rehabilitation unit at WVU Medicine United Hospital Center, which is now closed. Until the new hospital opens, Encompass Health Rehabilitation Hospital of Morgantown has increased its capacity to serve patients in the region.
The Bridgeport facility fits into Encompass Health’s long-term growth strategy of increasing capacity in markets where demand for rehabilitation services remains strong, strengthening its market share. It already operates 175 hospitals across 39 states and Puerto Rico, making it one of the largest providers of inpatient rehabilitation services in the country.
In 2026, the company expects to open eight new hospitals, adding 389 beds to its network. It also plans to increase capacity at existing facilities by 150 to 200 beds during the year. As of March 31, 2026, Encompass Health had 18 rehabilitation hospitals under development.
During first-quarter 2026 earnings, the company reaffirmed its growth plans for the 2023-2027 period, where it expects to inaugurate six to 10 de novo hospitals each year, as well as make bed additions in the range of 80-120 each year. It also projects discharge growth at a compound annual rate of 6-8% in the same time frame.
Price Performance
Shares of Encompass Health have lost 0.7% in the year-to-date period against the 7.3% growth of the industry.
Image Source: Zacks Investment Research
Zacks Rank and Key Picks
Encompass Health currently has a Zacks Rank #3 (Hold).
The Zacks Consensus Estimate for Tenet Healthcare’s 2026 bottom line suggests 5.3% year-over-year growth. It witnessed eight upward estimate revisions over the past 30 days against no movement in the opposite direction. Tenet Healthcare beat earnings estimates in each of the last four quarters, with the average surprise being 20.6%.
The Zacks Consensus Estimate for The Pennant Group’s current-year bottom line is pegged at $1.35 per share, which indicates 14.4% growth from a year ago. During the past 30 days, it witnessed one upward estimate revision against none in the opposite direction. The consensus mark for PNTG’s current year revenues predicts a 23.3% year-over-year increase.
The Zacks Consensus Estimate for Quest Diagnostics’ current-year earnings implies 8.6% improvement from the year-ago reported figure. It beat earnings estimates in each of the last four quarters, with an average surprise of 3.5%. The consensus mark for Quest Diagnostics’ current-year revenues indicates a 7.2% year-over-year increase.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Encompass Health to Expand WV Footprint With 36-Bed Bridgeport Unit
Key Takeaways
Encompass Health Corporation (EHC - Free Report) is continuing to expand its rehabilitation network with plans to build a new 36-bed inpatient rehabilitation hospital in Bridgeport, WV. The freestanding facility will provide specialized care for patients recovering from strokes, spinal cord injuries, brain injuries, amputations, neurological disorders and complex orthopedic conditions.
The project represents an expansion and relocation of the former 19-bed rehabilitation unit at WVU Medicine United Hospital Center, which is now closed. Until the new hospital opens, Encompass Health Rehabilitation Hospital of Morgantown has increased its capacity to serve patients in the region.
The Bridgeport facility fits into Encompass Health’s long-term growth strategy of increasing capacity in markets where demand for rehabilitation services remains strong, strengthening its market share. It already operates 175 hospitals across 39 states and Puerto Rico, making it one of the largest providers of inpatient rehabilitation services in the country.
In 2026, the company expects to open eight new hospitals, adding 389 beds to its network. It also plans to increase capacity at existing facilities by 150 to 200 beds during the year. As of March 31, 2026, Encompass Health had 18 rehabilitation hospitals under development.
During first-quarter 2026 earnings, the company reaffirmed its growth plans for the 2023-2027 period, where it expects to inaugurate six to 10 de novo hospitals each year, as well as make bed additions in the range of 80-120 each year. It also projects discharge growth at a compound annual rate of 6-8% in the same time frame.
Price Performance
Shares of Encompass Health have lost 0.7% in the year-to-date period against the 7.3% growth of the industry.
Zacks Rank and Key Picks
Encompass Health currently has a Zacks Rank #3 (Hold).
Investors can look at some better-ranked stocks in the broader Medical space, like Tenet Healthcare (THC - Free Report) ,The Pennant Group, Inc. (PNTG - Free Report) and Quest Diagnostics Incorporated (DGX - Free Report) , each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The Zacks Consensus Estimate for Tenet Healthcare’s 2026 bottom line suggests 5.3% year-over-year growth. It witnessed eight upward estimate revisions over the past 30 days against no movement in the opposite direction. Tenet Healthcare beat earnings estimates in each of the last four quarters, with the average surprise being 20.6%.
The Zacks Consensus Estimate for The Pennant Group’s current-year bottom line is pegged at $1.35 per share, which indicates 14.4% growth from a year ago. During the past 30 days, it witnessed one upward estimate revision against none in the opposite direction. The consensus mark for PNTG’s current year revenues predicts a 23.3% year-over-year increase.
The Zacks Consensus Estimate for Quest Diagnostics’ current-year earnings implies 8.6% improvement from the year-ago reported figure. It beat earnings estimates in each of the last four quarters, with an average surprise of 3.5%. The consensus mark for Quest Diagnostics’ current-year revenues indicates a 7.2% year-over-year increase.